Physician profile
James D Davenport
NPI 1235140823
$15,826.29
in general payments reported to CMS, 2019-2025
34 companies · $224 in 2025
The $224 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,474 · 2020: $1,262 · 2021: $2,213 · 2022: $3,566 · 2023: $3,178 · 2024: $2,909 · 2025: $224.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,312.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,311.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $8,013.16 | 2021-2025 | Micra, Mycarelink, Linq II |
| Medtronic Vascular, INC. | $2,310.49 | 2019-2020 | |
| Abbott Laboratories | $715.60 | 2021-2024 | Tacticath Ablation Catheter, Sensor Enabled, Tacticath, Advisor |
| Boston Scientific Corporation | $620.47 | 2021-2024 | Watchman Access System |
| E.R. Squibb & Sons, L.L.C. | $526.11 | 2019-2024 | Camzyos, Eliquis |
| Pfizer INC. | $438.47 | 2019-2024 | |
| Astrazeneca Pharmaceuticals Lp | $437.50 | 2019-2024 | Farxiga, Wainua |
| Janssen Pharmaceuticals, INC | $335.21 | 2019-2024 | Xarelto |
| Impulse Dynamics (USA) INC. | $301.57 | 2021-2022 | |
| Philips North America LLC | $293.06 | 2020-2024 | (Ck4) Mcot |
| Shockwave Medical, INC | $223.43 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Novartis Pharmaceuticals Corporation | $217.94 | 2020-2024 | |
| Merck Sharp & Dohme LLC | $188.96 | 2021-2024 | Verquvo |
| Amarin Pharma, INC. | $173.18 | 2019-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $148.48 | 2019-2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $143.06 | 2019 | |
| Biotronik INC. | $125.30 | 2019 | |
| Kestra Medical Technology Services, INC. | $81.75 | 2023-2024 | Assure Wcd |
| Irhythm Technologies, INC. | $71.63 | 2022-2024 | Zio Monitor, Zio Xt Patch |
| Novo Nordisk INC | $68.59 | 2023-2024 | Ozempic, Rybelsus, Wegovy |
| Cordis US Corp. | $58.46 | 2023-2024 | Mynx Control, Brite Tip Radianz |
| Atricure, INC. | $52.47 | 2022-2023 | |
| Amgen INC. | $36.25 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $35.77 | 2019 | |
| Baxter Healthcare | $26.61 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Cardiovascular Systems INC. | $24.64 | 2021 | |
| Heartflow, INC. | $23.84 | 2024 | |
| Vital Connect, INC | $23.46 | 2023 | Vitalpatch Rtm |
| Bayer Healthcare Pharmaceuticals INC. | $21.77 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $19.95 | 2024 | Arcalyst |
| Sanofi-Aventis U.S. LLC | $19.88 | 2022 | |
| Stryker Corporation | $17.48 | 2023 | Na |
| Preventice Services, LLC | $16.75 | 2021 | |
| Bardy Diagnostics, INC. | $15.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Davenport listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.